| Literature DB >> 28695397 |
Toshiaki Suzuki1,2, Ayano Yamamoto1, Masahiro Ohsawa3, Yoshiharu Motoo4, Hajime Mizukami1,5, Toshiaki Makino6.
Abstract
Oxaliplatin (L-OHP) is a platinum-based anticancer agent used to treat various types of cancer. It frequently causes acute and chronic peripheral neuropathies, such as cold allodynia and mechanical hyperalgesia. Ninjin'yoeito (NYT) is a formula used in traditional Japanese Kampo medicine to improve recovery from diseases and other medical disorders. We previously reported that treatment with a boiling-water extract of NYT prevented L-OHP-induced damage to neurite-like outgrowths from differentiated PC12 cells. The objectives of the present study were to evaluate the in vivo effects of NYT on L-OHP-induced neuropathic pain in mice and identify the active ingredients in NYT. Treatment with NYT extract significantly ameliorated both cold allodynia and mechanical hyperalgesia induced by L-OHP. While L-OHP treatment suppressed neurite outgrowths from primary dorsal root ganglion cells in vitro, NYT extract blocked this suppression in a concentration-dependent manner. Among the herbal components of NYT, the extract of ginseng (Panax ginseng roots) showed a protective effect against neurite damage induced by L-OHP, and one of its active ingredients was identified as ginsenoside Rg3. Ginseng extract partially relieved L-OHP-induced neuropathic pain in mice. Our results suggest that NYT could be an attractive agent for treating L-OHP-induced neuropathic pain, and that the active ingredient of NYT may be ginseng.Entities:
Keywords: Ginsenoside Rg3; Neuropathy; Ninjin’yoeito; Oxaliplatin; Root of Panax ginseng
Mesh:
Substances:
Year: 2017 PMID: 28695397 DOI: 10.1007/s11418-017-1113-6
Source DB: PubMed Journal: J Nat Med ISSN: 1340-3443 Impact factor: 2.343